William Blair & Company’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$875K Sell
7,701
-1,533
-17% -$174K ﹤0.01% 935
2025
Q1
$971K Sell
9,234
-14
-0.2% -$1.47K ﹤0.01% 894
2024
Q4
$991K Buy
9,248
+33
+0.4% +$3.54K ﹤0.01% 908
2024
Q3
$922K Buy
9,215
+80
+0.9% +$8.01K ﹤0.01% 924
2024
Q2
$770K Sell
9,135
-10
-0.1% -$843 ﹤0.01% 961
2024
Q1
$669K Sell
9,145
-11
-0.1% -$804 ﹤0.01% 1006
2023
Q4
$654K Sell
9,156
-975
-10% -$69.6K ﹤0.01% 996
2023
Q3
$607K Hold
10,131
﹤0.01% 1000
2023
Q2
$730K Sell
10,131
-95
-0.9% -$6.85K ﹤0.01% 944
2023
Q1
$752K Sell
10,226
-5
-0% -$368 ﹤0.01% 910
2022
Q4
$683K Sell
10,231
-6,169
-38% -$412K ﹤0.01% 949
2022
Q3
$881K Sell
16,400
-48
-0.3% -$2.58K ﹤0.01% 855
2022
Q2
$915K Sell
16,448
-3,274
-17% -$182K ﹤0.01% 875
2022
Q1
$1.38M Sell
19,722
-4,357
-18% -$306K ﹤0.01% 806
2021
Q4
$2.32M Buy
24,079
+167
+0.7% +$16.1K 0.01% 690
2021
Q3
$2.08M Buy
23,912
+460
+2% +$40K 0.01% 697
2021
Q2
$1.92M Sell
23,452
-22,963
-49% -$1.88M 0.01% 719
2021
Q1
$4.41M Sell
46,415
-5,432
-10% -$517K 0.02% 476
2020
Q4
$3.22M Buy
51,847
+12,771
+33% +$792K 0.01% 537
2020
Q3
$2.32M Buy
39,076
+4,640
+13% +$276K 0.01% 551
2020
Q2
$2.4M Sell
34,436
-1,599
-4% -$112K 0.01% 517
2020
Q1
$1.64M Sell
36,035
-10,171
-22% -$461K 0.01% 558
2019
Q4
$3.01M Buy
46,206
+426
+0.9% +$27.7K 0.02% 513
2019
Q3
$2.84M Sell
45,780
-82,248
-64% -$5.11M 0.02% 494
2019
Q2
$9.12M Sell
128,028
-17,104
-12% -$1.22M 0.05% 278
2019
Q1
$11.4M Sell
145,132
-88,414
-38% -$6.93M 0.07% 239
2018
Q4
$19.8M Buy
233,546
+17,314
+8% +$1.47M 0.14% 151
2018
Q3
$37M Sell
216,232
-5,075
-2% -$869K 0.23% 107
2018
Q2
$28.6M Buy
221,307
+9,365
+4% +$1.21M 0.19% 122
2018
Q1
$21.8M Buy
211,942
+15,728
+8% +$1.62M 0.15% 138
2017
Q4
$16.8M Sell
196,214
-3,031
-2% -$259K 0.11% 183
2017
Q3
$16.9M Sell
199,245
-8,467
-4% -$719K 0.13% 173
2017
Q2
$15.7M Buy
207,712
+2,555
+1% +$194K 0.12% 187
2017
Q1
$13.5M Buy
205,157
+21,343
+12% +$1.41M 0.11% 195
2016
Q4
$11.7M Buy
183,814
+46,825
+34% +$2.97M 0.1% 201
2016
Q3
$8.72M Buy
136,989
+27,948
+26% +$1.78M 0.08% 232
2016
Q2
$8.11M Buy
109,041
+5,413
+5% +$403K 0.08% 228
2016
Q1
$6.92M Buy
103,628
+5,053
+5% +$338K 0.07% 237
2015
Q4
$6.67M Sell
98,575
-119,393
-55% -$8.07M 0.06% 248
2015
Q3
$11.6M Sell
217,968
-2,141,076
-91% -$114M 0.1% 210
2015
Q2
$148M Buy
2,359,044
+18,707
+0.8% +$1.18M 0.22% 134
2015
Q1
$113M Buy
2,340,337
+472,779
+25% +$22.7M 0.17% 179
2014
Q4
$62M Buy
1,867,558
+175,878
+10% +$5.84M 0.1% 276
2014
Q3
$49.6M Buy
1,691,680
+339,211
+25% +$9.94M 0.08% 312
2014
Q2
$52.6M Sell
1,352,469
-149,015
-10% -$5.79M 0.09% 315
2014
Q1
$63M Sell
1,501,484
-415,677
-22% -$17.4M 0.1% 275
2013
Q4
$62.9M Buy
1,917,161
+1,570,804
+454% +$51.5M 0.1% 289
2013
Q3
$9.35M Buy
+346,357
New +$9.35M 0.02% 761